Most People would get a COVID-19 Vaccine if the Government or Employer Recommends it – RS News

Most People would get a COVID-19 Vaccine if the Government or Employer Recommends it

COVID-19

A global poll result showed that most people would get a coronavirus vaccine if the government or the employer recommends it.

According to the report, around 71.5% of participants said they would be very or somewhat likely to take a COVID-19 vaccine and 61.4% reported they would accept their employer’s recommendation to do so, according to the survey in June of more than 13,000 people in 19 countries.

The poll was supervised by the Vaccine Confidence Project (VCP), a global surveillance programme on vaccine trust funded by the European Commission and pharmaceutical companies among others, as well as Business Partners to CONVINCE, a U.S./British initiative that is partly government funded.

Must read: China’s Experimental Coronavirus Vaccine costs $60

All respondents, irrespective of nationality stated they would be less likely to accept a COVID-19 vaccine if it were mandated by employers.

There were regional differences in responses however it highlighted the polarisation in attitudes on the topic.

Around 90% of participants in China said they accepted a vaccine, but the rate in Russia was less than 55%. In France, the positive response rate 58.89%, compared with 75.4% in the United States and 71.48% in Britain.

At least 60-70% of the population would need to have immunity to break the chain of transmission, according to the World Health Organization.

Respondents were aged 18 years or older from 19 countries from among the top 35 countries affected by the pandemic in terms of cases per million population.

The results will likely provoke the debate about how to overcome public safety concerns, particularly in Western countries, about the frenetic speed of work to develop vaccines, potentially hampering efforts to control the pandemic and revive the global recovery.

There are almost 200 COVID-19 vaccine candidates in development worldwide. This includes 40 in human clinical trials to test for safety and effectiveness.

Leave a Reply

Your email address will not be published. Required fields are marked *